What steps is the FDA taking to impove public awareness of potential drug risks?
In light of the Vioxx fiasco, FDA drug chief Dr. Steven Galson told a congressional hearing in May 2005 that the agency is taking steps to improve awareness by the public and doctors of potential drug risks as soon as they arise. He said that what was happening with Vioxx wasn’t clear-cut until the research was completed the previous summer. He also acknowledged that it may have taken too long to put a new warning label on the drug.
